Global Pulmonary Arterial Hypertension Market size is expected to be worth around USD 12.3 Billion by 2033 from USD 7.3 Billion in 2023, growing at a CAGR of 5.4% during the forecast period from 2023 to 2033.

Pulmonary Arterial Hypertension Market Trends and Growth | Report 2033

Pulmonary Arterial Hypertension Market

Global Pulmonary Arterial Hypertension Market (By Drug Class (Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators), By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), By Region and Companies)